Faced with generic rivals, Amarin cuts 400-plus sales reps as part of revamped Vascepa strategy

Faced with generic rivals, Amarin cuts 400-plus sales reps as part of revamped Vascepa strategy
nhigginsdunn
Thu, 09/23/2021 – 09:52